Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated - Wikidata - awgldk - TriplyDB

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

http://www.wikidata.org/entity/Q33733756

about

Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia Prostate cancer stem cells: the role of androgen and estrogen receptors Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer Estrogens in Male Physiology Development of subtype-selective oestrogen receptor-based therapeutics.Emerging medication for the treatment of male hypogonadism.Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations.Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding.The role of estrogen receptor β in prostate cancer.Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.Differential expression of estrogen receptor beta isoforms in prostate cancer through interplay between transcriptional and translational regulation Estrogen action and prostate cancer.Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity Estrogens and prostate cancer: etiology, mediators, prevention, and management.Androgens and estrogens in benign prostatic hyperplasia: past, present and future.Sex-associated difference in estrogen receptor β expression in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancers in rats Estrogen receptor β exon 3-deleted mouse: The importance of non-ERE pathways in ERβ signaling Structural and Functional Diversity of Estrogen Receptor Ligands.Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats.Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation.Trans-, cis-, and dihydro-resveratrol: a comparative study.A lack of ovarian function increases neuroinflammation in aged mice.Nuclear receptors as modulators of the tumor microenvironment.Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.Linking obesogenic dysregulation to prostate cancer progression.Estrogen receptor β in Alzheimer's disease: From mechanisms to therapeutics.Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia.Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway.Estrogen receptors and human disease: an update.Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells.Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome

P2860

Q26741226-B44C7013-55A7-43B4-8DD8-125B8221943E Q26778415-D00A2471-FF57-41D4-B39A-43213736CD4D Q28071946-C3343EDC-6AB8-445B-A2A8-B62DD9E14908 Q28087001-02E8EA0D-BEA4-46F0-BCFC-B22D8A897C59 Q28261485-F89705B9-474E-41C8-BED1-6D905C03627E Q28276867-9A7F4310-E242-40A4-BEEE-9BF2C9487D0D Q30090708-437157F2-7123-4D25-AF3A-F8AA91AB2438 Q34216817-9B385060-541E-480D-8E4F-9934C83D79BF Q34276286-548FC28C-C622-4986-B674-C3FE7BB38720 Q34315419-FD2FEA0E-35BC-400C-AF54-919D7CDC0688 Q34342340-2D55948F-87B1-4FDB-891D-BB3FC455FA12 Q34360076-87A96BAC-F978-49B0-BB48-F1237DEC6875 Q34416254-F47BCEF5-3027-42EF-988C-06E226F44CAF Q34524093-6FF72EB6-0DC8-4A26-98C1-EF48297655D7 Q35056593-DE56C40B-7BD6-4530-8094-C65E6E2FA6FB Q35099011-28BD8841-5E77-4418-A99C-15888D8F1A38 Q35176093-B22D19AC-4567-4D81-9C9A-EE4BC86CE899 Q35196710-8B601E59-FF16-4C7D-B342-9521B47C1D82 Q35231660-18AAF5A0-1F3C-41DF-AEC1-E88D1F62F959 Q35343567-86F28C72-1142-478C-94B4-19C87BDE632F Q35549236-E58FB789-334D-426A-8952-882CB856C09F Q35599990-7CC9FC53-494B-4DD7-9D01-CBC9C2A36366 Q35683915-3A7C0EB0-D2BA-416D-8DBA-CB134EC16277 Q35725686-1FB90AB9-0B57-4CE0-BFD8-550279F860B9 Q35793871-CD11F413-9601-4CE4-8AFE-1BC4B1F039CF Q35850489-7A52A2C0-8631-4541-8076-68B9B22BBD51 Q35856568-82389A50-05E3-4D5C-BFC4-144433C25586 Q35986045-2B1B49CB-0CD6-4CFD-841F-DB0A7E875572 Q36127288-CBB9A078-E229-4D4B-B786-807D30035C60 Q36175547-E90629A8-75FA-448B-AB81-ED0755FFC092 Q36300793-6DB96185-948B-48D4-8556-DD0F24614708 Q36322578-F2833F40-774C-4C7A-8B1E-BA24FC554518 Q36326380-08B4FE05-6B8E-4E77-85B6-85516ACD1630 Q36335781-269C6B39-1565-423C-B9EE-BC13211386AE Q36434014-102E143F-420A-49AC-910E-519F86EDAEEB Q36661810-A95FA28F-EBA7-4105-9BC2-9F2A31A112EA Q37078703-20DA6E06-4B0E-4FA6-A06F-043D36AE9F75 Q37161245-A5E5A31D-E206-4D95-9FFA-912C4B19D6B5 Q37185881-D2602A81-2512-458E-901A-CFC7C2C6DCB3 Q37244198-92270F3A-9B2A-485F-8C61-71DA57565A3A

P2860

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

http://www.wikidata.org/entity/Q33733756

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@ast

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@en

type

label

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@ast

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@en

prefLabel

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@ast

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@en

P1433

Q33733756-B8BD6BF5-6ABA-451B-A9E2-D8453B3227DF

P1476

Q33733756-CDE8A5F3-1D81-49C3-8D3C-C36BFC0429FC

P2093

Q33733756-1DD5D570-F93F-49E3-BD44-F9F9F5503657

Q33733756-30A3189B-50A7-4679-8035-38BE5C22C9A6

Q33733756-6E9639DD-EEA2-4B88-99FA-48247AF84FCB

Q33733756-79C7B6BC-C987-47AC-B22D-A707DCED5910

Q33733756-851083C8-DC0C-443B-83F1-1C55CEDC775F

Q33733756-95C4E3DF-6D2C-48D5-9716-F0C7EA2CEF24

Q33733756-AD22CE56-FB32-43A5-BA02-9F5BFAEEAD0E

Q33733756-B72B3165-1A5F-41B1-A99F-EC2C12015853

Q33733756-B997A678-726C-4122-BCDD-22F770F220E4

Q33733756-E26CA9B7-3DB8-46D0-B6EB-3ABC6F1F8387

P2860

Q33733756-05B85321-5953-48AD-8B70-90F6FB2486B2

Q33733756-19F287C6-1E2B-4240-B2D4-530E26FCCA9C

Q33733756-1A57CFB2-461D-49CC-910B-4B401DAAAD8F

Q33733756-2D46B86C-A6F5-47C7-9104-EAAA7ADA4AA1

Q33733756-32749552-583B-4B6B-A70C-C5F1F405FA8F

Q33733756-3640AAA0-F402-4F98-8FA6-0848AB8DABF6

Q33733756-39817404-F77D-4D6E-AAE2-41025A29AA0A

Q33733756-3A518679-5CFF-454E-B32D-15005B9C19A1

Q33733756-3EA014E3-7407-4C1B-914B-A637F06B5688

Q33733756-516C7CCE-CE4A-4FDA-9947-A4799FEB6E8A

P304

Q33733756-58D94C0C-400D-4FA6-9CA0-97BF51703772

P31

Q33733756-4AAF576F-C5B8-41B0-92F7-14ACBBE1099A

P356

Q33733756-ACB4AE95-EA16-4D87-85D2-B335C1C1E9A4

P407

Q33733756-22895B4D-62B7-4D2A-8C61-99B4F23D079C

P433

Q33733756-25B688EF-F55E-411C-A870-BC1BC98055E1

P478

Q33733756-7F89C577-72D9-4A95-9F1B-34F30EFA2D4F

P577

Q33733756-3A7CD2AA-4297-4AE0-AF6F-04AD1DE08717

P5875

Q33733756-DADEF20A-3F6F-4585-B7F2-7A37C9633303

P698

Q33733756-F23C446A-0E61-406B-A0D1-4218B5A258AB

P932

Q33733756-B0DFC5F4-997A-44F0-9265-F00DB0F37EF5

P356

PNAS.0905524107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Estrogen receptor-beta activat ...... ependent and TNFalpha mediated

@en

P2093

Birunthi Niranjan

http://www.w3.org/2001/XMLSchema#string

Gail P Risbridger

http://www.w3.org/2001/XMLSchema#string

Michael Grant

http://www.w3.org/2001/XMLSchema#string

Preetika Balanathan

http://www.w3.org/2001/XMLSchema#string

Renea A Taylor

http://www.w3.org/2001/XMLSchema#string

Roxanne Toivanen

http://www.w3.org/2001/XMLSchema#string

Shelley L Hedwards

http://www.w3.org/2001/XMLSchema#string

Shirin Hussain

http://www.w3.org/2001/XMLSchema#string

Stephen J McPherson

http://www.w3.org/2001/XMLSchema#string

Upeksha P Chandrasiri

http://www.w3.org/2001/XMLSchema#string

P2860

An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth

Generation of a prostate from a single adult stem cell

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta

A phase 1-2 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma

Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate

Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue

Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland

Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene

Prospective identification of tumorigenic prostate cancer stem cells

P304

3123-3128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0905524107

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41408509

http://www.w3.org/2001/XMLSchema#string

P698

20133657

http://www.w3.org/2001/XMLSchema#string

P932

2840300

http://www.w3.org/2001/XMLSchema#string